MRKR — Marker Therapeutics Share News
0.000.00%
Last trade - 00:00- $16.01m
- $4.68m
- $3.55m
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Marker Therapeutics 2025 net loss widens, hurt by decline in grant income
Brief: Marker Therapeutics FY Basic EPS USD -0.79
Marker Therapeutics Q3 net loss narrows to $2 mln
Brief: Marker Therapeutics Appoints Kathryn Penkus Corzo To Board Of Directors
U.S. STOCKS ON THE MOVE-Advanced Micro Devices, ImmunityBio, Trump Media
U.S. STOCKS ON THE MOVE-Trump Media, Gold miners, Cracker Barrel
U.S. STOCKS ON THE MOVE-Constellation Brands, Bank of Montreal, Advanced Micro Devices
Marker Therapeutics jumps after blood cancer trial data
Marker Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Marker Therapeutics Reports that Lymphodepletion Improves the Expansion and Persistence of Multi-Antigen Recognizing T Cells in Patients with Lymphoma
Marker Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Marker Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Marker Therapeutics Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Marker Therapeutics Inc Files For Resale Of Up To 10.1 Million Shares By The Selling Stockholders - SEC Filing
U.S. STOCKS ON THE MOVE-Darden Restaurants, Natgas firms, Affirm Holdings
U.S. STOCKS ON THE MOVE-Paychex, RTX, Boeing